Rentschler enters agreement with Genmab for antibody manufacture

Date Published06/04/2020
Author NameBen Hargreaves
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Rentschler Biopharma
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):75
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Country(ies) from which reshored:Germany
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredantibodies
What domestic positive factors made reshoring more attractive?Proximity to customers/market, covid-19?
Find Reshoring Articles